References
Duarte BMF, Pinheiro R, Cabete J. Multiple miliary osteoma cutis: a comprehensive review and update of the literature. Eur J Dermatol 2018; 28: 435–40.
Novak C, Siller G, Wood D. Idiopathic multiple miliary osteomas of the face. Australas J Dermatol 1998; 39: 109–11.
Chabra IS, Obagi S. Evaluation and management of multiple miliary osteoma cutis: case series of 11 patients and literature review. Dermatol Surg 2014; 40: 66–8.
Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 2012; 30: 3–16.
Feliciani C, Joly P, Jonkman MF, et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol 2015; 172: 867–77.
Cozzani E, Gasparini G, Di Zenzo G, Parodi A. IgE and bullous pemphigoid. Eur J Dermatol 2018; 28: 441–9.
Hessam S, Gambichler T, Skrygan M, et al. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions. Eur J Dermatol 2018.
Zhang Q, Zhao K, Shen Q, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 2015; 525: 389–93.
Figueroa ME, Abdel-Wahab O, Lu C, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18: 553–67.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Cunha, N., Hernandez-Aragues, I., Fattouh, K. et al. Residents’corner, July-August 2018 What’s new this month?. Eur J Dermatol 28, 565–566 (2018). https://doi.org/10.1684/ejd.2018.3384
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3384